For you market people, this weeks Prostate Cancer Weekly from UroToday has the following:
Reno, Nevada (UroToday.com) -- Prostatype Genomics AB ("Prostatype Genomics" or the "Company") announces that the Company’s shares will begin trading on the OTCQB Venture Market in the United States on March 13, 2025. Prostatype Genomics’ ordinary share will thus be tradable, in parallel to its current Nasdaq First North listing in Stockholm, during U.S. market hours, with a U.S. ticker symbol OTCQB: PGABF and priced in USD to enable access to U.S. broker/dealers and investors.